Journals / Tüberküloz ve Toraks / 2010 / Cilt: 58 - Sayı: 3

Venous thromboembolism in intensive care unit patients

Yoğun bakım hastalarında venöz tromboembolizm

Pages
321–333
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, it has been aimed to remind VTE issue in the intensive care units, by review the investigations about the diagnosis, treatment and thromboprophylaxis of VTE.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In intensive care units, venous thromboembolism (VTE) is a life threatening, clinically important issue.
📊
Key Findings & Data:The diagnosis of VTE is significantly complicated, even in patients except intensive care units and there is no consensus between clinicians about its treatment.
💡
Conclusion & Impact:In this review, it has been aimed to remind VTE issue in the intensive care units, by review the investigations about the diagnosis, treatment and thromboprophylaxis of VTE.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In intensive care units, venous thromboembolism (VTE) is a life threatening, clinically important issue. The diagnosis of VTE is significantly complicated, even in patients except intensive care units and there is no consensus between clinicians about its treatment. The factors such as heterogeneity of intensive care units patients, the association of thrombosis and bleeding risks in the majority of patients, the non-specific signs and symptoms of VTE, the feasibility limitations of diagnostic methods are caused difficulties in the diagnosis and treatment of VTE. In this review, it has been aimed to remind VTE issue in the intensive care units, by review the investigations about the diagnosis, treatment and thromboprophylaxis of VTE.

Özet

Yoğun bakım ünitelerinde venöz tromboembolizm (VTE) yaşamı tehdit eden önemli bir klinik sorundur. Yoğun bakım dışı hastalarda bile VTE tanısı oldukça karmaşık olup, tedavisi konusunda klinisyenler arasında fikir birliği yoktur. Yoğun bakım hastalarının heterojen olması, çoğunda tromboz ve kanama riskinin bir arada olması, VTE'nin nonspesifik belirti ve bulgularla seyretmesi, tanısal yöntemlerin uygulanabilirliğinin sınırlı olması gibi faktörler hastalığın sıklığının belirlenmesinde, tanı ve tedavisinde güçlüklere neden olmaktadır. Bu yazıda, yoğun bakım hastalarında VTE tanısı, tedavisi ve tromboprofilaksisi ile ilgili çalışmalar derlenerek yoğun bakım ünitelerindeki VTE sorununa dikkati çekmek amaçlanmıştır.

🔖

Cite This Article

HABEŞOĞLU, M. A., EYÜBOĞLU, F. Ö. (2022). Venous thromboembolism in intensive care unit patients. Tüberküloz ve Toraks, Cilt: 58 - Sayı: 3, 321–333. https://ajindex.com/articles/618850

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Moser KM, Fedullo PF, LitteJohn JK, et al. Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis. JAMA 1994; 271: 223-5
  2. Cook DJ, Crowther MA, Meade MO, et al. Prevalance, incidence, and risk factors for venous thromboembolism in medical-surgical intensive care unit patients. J Crit Care 2005; 20: 309-13
  3. Harris LM, Curl RC, Booth FV, et al. Screening for asymptomatic deep vein thrombosis in surgical intensive care patients. J Vase Surg 1997; 26: 764-9
  4. Schonhofer B, Kohler D. Prevalence of deep-vein thrombosis of the leg in patients with acute exacerbation of chronic obstructive pulmonary disease. Respiration 1998; 65: 173-7
  5. Hirsch DR, Ingenito EP, Goldhaber SZ. Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA 1995; 274: 335-7
  6. Marik PE, Andrews L, Maini B. The incidence of deep venous thrombosis in ICU patients. Chest 1997; 111: 661-4
  7. Patel R, Cook DJ, Meade MO, et al. Burden of illness in venous thromboembolism in critical care: a multicenter observational study. J Crit Care 2005; 20: 341-7
  8. Cook D, Attia J, Weaver B, et al. Venous thromboembolic disease: an observational study in medical-surgical intensive care unit patients. J Crit Care 2000; 15: 127-32
  9. Selby R, Geerts WH. Venous thromboembolism: risk factors and prophylaxis. Semin Respir Crit Care Med 2000; 21: 493-501
  10. Geerts W, Cook D, Selby R, et al. Venous thromboembolism and its prevention in critical care. J Crit Care 2002; 17: 95-104
  11. International Consensus Statement: thrombophilia and venous thromboembolism. Int Angiol 2005; 24: 1-26
  12. Crowther MA, Cook DJ, Meade M, et al. Baseline thrombophilic markers do not predict venous thrombosis in medicalsurgical ICU patients. J Thromb Heamost 2003; 1: 0925
  13. Bernard GR, Vincent JL, Laterre PF, et al. Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699-709
  14. Baudo F, Caimi TM, de Cataldo F, et al. Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study. Intensive Care Med 1998; 24: 336-42
  15. Wells PS, Anderson DR, Rodger M, et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D dimer. Thromb Haemost